Literature DB >> 2510837

Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.

B P Hazenberg1, M A Van Leeuwen, M H Van Rijswijk, A C Stern, E Vellenga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510837

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  43 in total

1.  Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice.

Authors:  I K Campbell; A Bendele; D A Smith; J A Hamilton
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome--a case report.

Authors:  U Kaiser; M Klausmann; G Richter; K H Pflüger
Journal:  Ann Hematol       Date:  1992-04       Impact factor: 3.673

3.  Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.

Authors:  A R Gari-Bai; C Rochlitz; M Riewald; J Oertel; D Huhn
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

Review 4.  [New biologics and orally available compounds. What is still in the pipeline?].

Authors:  M Grünke; H Bastian; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

5.  Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation.

Authors:  R J Bischof; D Zafiropoulos; J A Hamilton; I K Campbell
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 6.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

7.  Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.

Authors:  K Bendtzen; P R Hansen; K Rieneck
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

8.  Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.

Authors:  H Wandt; M Seifert; C Falge; W M Gallmeier
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

9.  GM-CSF and G-CSF in Felty's syndrome.

Authors:  D R Wagner; C Combe; U Gresser
Journal:  Clin Investig       Date:  1993-02

10.  Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF).

Authors:  S Q Hayat; M Hearth-Holmes; R E Wolf
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.